Cue Biopharma, Inc. (CUE)
NASDAQ: CUE · Real-Time Price · USD
0.5801
-0.0899 (-13.42%)
At close: Apr 22, 2026, 4:00 PM EDT
0.5999
+0.0198 (3.41%)
After-hours: Apr 22, 2026, 7:58 PM EDT

Cue Biopharma Revenue

In the year 2025, Cue Biopharma had annual revenue of $27.47M with 195.75% growth. Cue Biopharma had revenue of $21.94M in the quarter ending December 31, 2025, with 1,292.26% growth.

Revenue (ttm)
$27.47M
Revenue Growth
+195.75%
P/S Ratio
2.06
Revenue / Employee
$947,103
Employees
29
Market Cap
56.65M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202527.47M18.18M195.75%
Dec 31, 20249.29M3.80M69.16%
Dec 31, 20235.49M4.25M340.96%
Dec 31, 20221.25M-13.70M-91.67%
Dec 31, 202114.94M11.79M373.68%
Dec 31, 20203.15M-304.00K-8.79%
Dec 31, 20193.46M2.32M202.67%
Dec 31, 20181.14M--
Dec 31, 2017---
Dec 31, 2016---
Dec 31, 2015---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
ImmuCell27.64M
MindWalk Holdings20.70M
ImageneBio800.00K
Spruce Biosciences697.00K
MediciNova409.66K
iBio, Inc.300.00K
Revenue Rankings